Transcriptome analysis of circulating immune cell subsets highlight the role of monocytes in Zaire Ebola Virus Makona pathogenesis

Frontiers in Immunology

Volumn 8, Issue OCT, 2017, Pages

  Menicucci, Andrea R ^a   Versteeg, Krista ^b,c   Woolsey, Courtney ^b,c   Mire, Chad E ^b,c   Geisbert, Joan B ^b,c   Cross, Robert W ^b,c   Agans, Krystle N ^b,c   Jankeel, Allen ^d   Geisbert, Thomas W ^b,c   Messaoudi, Ilhem ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Galveston National Laboratory   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ebola; Hemorrhagic fever; Monocytes; Pathogenesis; RNASeq

Indexed keywords

CD2 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; INTERFERON REGULATORY FACTOR 7; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; SERINE PROTEINASE INHIBITOR; SERPIN G; SIALOADHESIN; STAT1 PROTEIN; STAT2 PROTEIN; TETRATRICOPEPTIDE REPEAT PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CELL SEPARATION; DOWN REGULATION; EBOLA HEMORRHAGIC FEVER; FLOW CYTOMETRY; GENE ONTOLOGY; INFLAMMATION; INNATE IMMUNITY; MACACA FASCICULARIS; MALE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; RNA SEQUENCE; TETRATRICOPEPTIDE REPEAT; VIRUS PATHOGENESIS; ZAIRE EBOLAVIRUS;

EID: 85032708967     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01372     Document Type: Article

References (70)

1. Feldmann H, Sanchez A, Geisbert TW. "Filoviridae: Marburg and Ebola viruses," in Fields Virology. Vol. 1. 6th ed. Philadelphia, PA: Wolters Kluwer (2013).
2. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet (2011) 377(9768):849-62. doi:10.1016/S0140-6736(10)60667-8
3. CDC. 2014 Ebola Outbreak in West Africa-Case Counts. (2016). Available from: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html
4. Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol (2003) 163(6):2347-70. doi:10.1016/S0002-9440(10)63591-2
5. Hensley LE, Young HA, Jahrling PB, Geisbert TW. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett (2002) 80(3):169-79. doi:10.1016/S0165-2478(01)00327-3
6. Stroher U, West E, Bugany H, Klenk HD, Schnittler HJ, Feldmann H. Infection and activation of monocytes by Marburg and Ebola viruses. J Virol (2001) 75(22):11025-33. doi:10.1128/JVI.75.22.11025-11033.2001
7. Gupta M, Mahanty S, Ahmed R, Rollin PE. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology (2001) 284(1):20-5. doi:10.1006/viro.2001.0836
8. Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, et al. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol (2002) 128(1):163-8. doi:10.1046/j.1365-2249.2002.01800.x
9. Ebihara H, Rockx B, Marzi A, Feldmann F, Haddock E, Brining D, et al. Host response dynamics following lethal infection of rhesus macaques with Zaire Ebolavirus. J Infect Dis (2011) 204(Suppl 3):S991-9. doi:10.1093/infdis/jir336
10. Sanchez A, Lukwiya M, Bausch D, Mahanty S, Sanchez AJ, Wagoner KD, et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol (2004) 78(19):10370-7. doi:10.1128/JVI.78.19.10370-10377.2004
11. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 179(Suppl 1):S188-91. doi:10.1086/514283
12. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis (2010) 4(10):e837. doi:10.1371/journal.pntd.0000837
13. Gupta M, Mahanty S, Bray M, Ahmed R, Rollin PE. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J Virol (2001) 75(10):4649-54. doi:10.1128/JVI.75.10.4649-4654.2001
14. Baize S, Leroy EM, Mavoungou E, Fisher-Hoch SP. Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system? Apoptosis (2000) 5(1):5-7. doi:10.1023/A:1009657006550
15. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest (2000) 80(2):171-86. doi:10.1038/labinvest.3780021
16. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis (2003) 188(11):1618-29. doi:10.1086/379724
17. Martinez O, Johnson JC, Honko A, Yen B, Shabman RS, Hensley LE, et al. Ebola virus exploits a monocyte differentiation program to promote its entry. J Virol (2013) 87(7):3801-14. doi:10.1128/JVI.02695-12
18. Jaax NK, Davis KJ, Geisbert TJ, Vogel P, Jaax GP, Topper M, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med (1996) 120(2):140-55.
19. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5(4):423-6. doi:10.1038/7422
20. Reed DS, Hensley LE, Geisbert JB, Jahrling PB, Geisbert TW. Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol (2004) 17(3):390-400. doi:10.1089/vim.2004.17.390
21. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol (2003) 163(6):2371-82. doi:10.1016/S0002-9440(10)63592-4
22. Gupta M, Spiropoulou C, Rollin PE. Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro. Virology (2007) 364(1):45-54. doi:10.1016/j.virol.2007.02.017
23. Connolly BM, Steele KE, Davis KJ, Geisbert TW, Kell WM, Jaax NK, et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis (1999) 179(Suppl 1):S203-17. doi:10.1086/514305
24. Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol (1998) 72(4):3155-60.
25. Yaddanapudi K, Palacios G, Towner JS, Chen I, Sariol CA, Nichol ST, et al. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J (2006) 20(14):2519-30. doi:10.1096/fj.06-6151com
26. Versteeg K, Menicucci AR, Woolsey C, Mire CE, Geisbert JB, Cross RW, et al. Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants. Sci Rep (2017) 7(1):9730. doi:10.1038/s41598-017-09963-y
27. Marzi A, Feldmann F, Hanley PW, Scott DP, Gunther S, Feldmann H. Delayed disease progression in cynomolgus macaques infected with Ebola virus Makona strain. Emerg Infect Dis (2015) 21(10):1777-83. doi:10.3201/eid2110.150259
28. Backman TWH, Girke T. systemPipeR: NGS workflow and report generation environment. BMC Bioinformatics (2016) 17:388. doi:10.1186/s12859-016-1241-0
29. Alasoo K, Martinez FO, Hale C, Gordon S, Powrie F, Dougan G, et al. Transcriptional profiling of macrophages derived from monocytes and iPS cells identifies a conserved response to LPS and novel alternative transcription. Sci Rep (2015) 5:12524. doi:10.1038/srep12524
30. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist (1979) 6(2):65-70.
31. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol (2002) 20:55-72. doi:10.1146/annurev.immunol.20.091301.131133
32. Hofer TP, Zawada AM, Frankenberger M, Skokann K, Satzl AA, Gesierich W, et al. Slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation. Blood (2015) 126(24):2601-10. doi:10.1182/blood-2015-06-651331
33. Grunin M, Hagbi-Levi S, Rinsky B, Smith Y, Chowers I. Transcriptome analysis on monocytes from patients with neovascular age-related macular degeneration. Sci Rep (2016) 6:29046. doi:10.1038/srep29046
34. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, Scholz GM, et al. Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. J Immunol (2012) 188(11):5752-65. doi:10.4049/jimmunol.1103426
35. Reiman JM, Kmieciak M, Manjili MH, Knutson KL. Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol (2007) 17(4):275-87. doi:10.1016/j.semcancer.2007.06.009
36. Frankenberger M, Hofer TP, Marei A, Dayyani F, Schewe S, Strasser C, et al. Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint. Eur J Immunol (2012) 42(4):957-74. doi:10.1002/eji.201141907
37. Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 32:513-45. doi:10.1146/annurev-immunol-032713-120231
38. O'Reilly MK, Paulson JC. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci (2009) 30(5):240-8. doi:10.1016/j.tips.2009.02.005
39. Daly C, Rollins BJ. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation (2003) 10(3-4):247-57. doi:10.1080/713773639
40. Modi WS. CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17ql2. Genomics (2004) 83(4):735-8. doi:10.1016/j.ygeno.2003.09.019
41. Muralidharan S, Mandrekar P. Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol (2013) 94(6):1167-84. doi:10.1189/jlb.0313153
42. Bale MD, Mosher DF. Thrombospondin is a substrate for blood coagulation factor XIIIa. Biochem (1986) 25(19):5667-73. doi:10.1021/bi00367a048
43. Vogler M. BCL2A1: the underdog in the BCL2 family. Cell Death Differ (2012) 19(1):67-74. doi:10.1038/cdd.2011.158
44. Weisiger RA, Fridovich I. Mitochondrial superoxide dismutase-site of synthesis and intramitochondrial localization. J Biol Chem (1973) 248(13):4793-6.
45. McNeill E, Crabtree MJ, Sahgal N, Patel J, Chuaiphichai S, Iqbal AJ, et al. Regulation of iNOS function and cellular redox state by macrophage Gch1 reveals specific requirements for tetrahydrobiopterin in NRF2 activation. Free Radic Biol Med (2015) 79:206-16. doi:10.1016/j.freeradbiomed.2014.10.575
46. Johnson C, Sung HJ, Lessner SM, Fini ME, Galis ZS. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues-potential role in capillary branching. Circ Res (2004) 94(2):262-8. doi:10.1161/01.RES.0000111527.42357.62
47. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity (2007) 27(1):111-22. doi:10.1016/j.immuni.2007.05.016
48. Hammond MEW, Lapointe GR, Feucht PH, Hilt S, Gallegos CA, Gordon CA, et al. Il-8 Induces neutrophil chemotaxis predominantly via type-I Il-8 receptors. J Immunol (1995) 155(3):1428-33.
49. Van Damme J, Proost P, Lenaerts JP, Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med (1992) 176(1):59-65. doi:10.1084/jem.176.1.59
50. Tsai SF, Tao M, Ho LI, Chiou TW, Lin SZ, Su HL, et al. Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells. Oncotarget (2016) 8(3):4051-61. doi:10.18632/oncotarget.13266
51. Feder ME, Hofmann GE. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu Rev Physiol (1999) 61:243-82. doi:10.1146/annurev.physiol.61.1.243
52. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, et al. Inhibition of death receptor signals by cellular FLIP. Nature (1997) 388(6638):190-5. doi:10.1038/40657
53. Ma O, Cai WW, Zender L, Dayaram T, Shen J, Herron AJ, et al. MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res (2009) 69(6):2559-67. doi:10.1158/0008-5472.CAN-08-2929
54. Rahman N, Stewart G, Jones G. A role for the atopy-associated gene PHF11 in T-cell activation and viability. Immunol Cell Biol (2010) 88(8):817-24. doi:10.1038/icb.2010.57
55. Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, Azuma M. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci U S A (2008) 105(30):10495-500. doi:10.1073/pnas.0802423105
56. Sanchez A, Kiley MP. Identification and analysis of Ebola virus messenger RNA. Virology (1987) 157(2):414-20. doi:10.1016/0042-6822(87)90283-2
57. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol (2006) 80(8):4174-8. doi:10.1128/JVI.80.8.4174-4178.2006
58. Wahl-Jensen V, Kurz S, Feldmann F, Buehler LK, Kindrachuk J, DeFilippis V, et al. Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression. PLoS Negl Trop Dis (2011) 5(10):e1359. doi:10.1371/journal.pntd.0001359
59. Escudero-Perez B, Volchkova VA, Dolnik O, Lawrence P, Volchkov VE. Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS Pathog (2014) 10(11):e1004509. doi:10.1371/journal.ppat.1004509
60. Pulit-Penaloza JA, Scherbik SV, Brinton MA. Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells. Virology (2012) 425(2):82-94. doi:10.1016/j.virol.2012.01.006
61. Spurgers KB, Alefantis T, Peyser BD, Ruthel GT, Bergeron AA, Costantino JA, et al. Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen. Mol Cell Proteomics (2010) 9(12):2690-703. doi:10.1074/mcp.M110.003418
62. Reid SP, Shurtleff AC, Costantino JA, Tritsch SR, Retterer C, Spurgers KB, et al. HSPA5 is an essential host factor for Ebola virus infection. Antiviral Res (2014) 109:171-4. doi:10.1016/j.antiviral.2014.07.004
63. Cilloniz C, Ebihara H, Ni C, Neumann G, Korth MJ, Kelly SM, et al. Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol (2011) 85(17):9060-8. doi:10.1128/JVI.00659-11
64. Ruibal P, Oestereich L, Ludtke A, Becker-Ziaja B, Wozniak DM, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature (2016) 533(7601):100-4. doi:10.1038/nature17949
65. Liu X, Speranza E, Munoz-Fontela C, Haldenby S, Rickett NY, Garcia-Dorival I, et al. Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus. Genome Biol (2017) 18(1):4. doi:10.1186/s13059-016-1137-3
66. Kash JC, Walters KA, Kindrachuk J, Baxter D, Scherler K, Janosko KB, et al. Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease. Sci Transl Med (2017) 9(385):eaai9321. doi:10.1126/scitranslmed.aai9321
67. Hilkens CM, Schlaak JF, Kerr IM. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol (2003) 171(10):5255-63. doi:10.4049/jimmunol.171.10.5255
68. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science (2013) 340(6129):202-7. doi:10.1126/science.1235208
69. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science (2013) 340(6129):207-11. doi:10.1126/science.1235214
70. Leung LW, Park MS, Martinez O, Valmas C, Lopez CB, Basler CF. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells. Immunol Cell Biol (2011) 89(7):792-802. doi:10.1038/icb.2010.169